相关实验视频

Updated: May 13, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

与瘤相关的长非编码RNAs在扩散性质瘤中表现变异,并在质母细胞瘤中沉默后对细胞生长产生影响

Joonas Uusi-Mäkelä¹, Maria Kauppinen^1,2, Janne Seppälä¹

¹Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Scientific reports

|May 9, 2025

概括

新发现的长非编码RNAs (lncRNAs) 在扩散性质瘤中表现异常,其中一些影响质母细胞瘤细胞生长. 这些lncRNAs可以作为新的生物标记物和脑瘤的治疗点.

科学领域:

* 分子生物学 * 分子生物学
* 瘤学瘤学是一门专业.
* 基因组学是一个学科.

背景情况:

*长非编码RNAs (lncRNAs) 越来越多地被认为对癌症的作用.
* 它们的特定表达模式表明它们有可能作为诊断和预后生物标志物.
*质母细胞瘤 (GBM) 是一种具有侵略性的脑瘤,需要更好的生物标志物和治疗策略.

研究的目的:

* 识别和表征质母细胞瘤 (GBM) 中的新型,未表征的长非编码RNA (lncRNAs).
*研究这些lncRNAs在扩散性质瘤中的表达模式及其与瘤特征和患者存活率的相关性.
* 评估GBM细胞系中选择的lncRNAs的功能相关性.

主要方法:

*来自癌症基因组图谱 (TCGA) 质母细胞瘤样本的RNA测序 (RNA-seq) 数据.
*在扩散性结质瘤和正常大脑队列中的表达分析 (TCGA,基因型-组织表达).
* 功能性研究涉及IncRNA在GBM细胞系 (SNB19) 中的淘汰.

主要成果:

*鉴定了22种新的lncRNAs,发现与正常脑组织相比,在扩散性结质瘤中具有上调调节.
*这些lncRNA的91%显示出瘤等级/实体之间显著的表达差异,64%与患者的存活相关.
* 抑制三个特定的lncRNAs (TCONS_l2_00001282,Inc-GBMT-6,Inc-NBN-1) 减少了GBM细胞的生长和殖民地形成.

结论:

* 鉴定到的 lncRNAs 与扩散性质瘤进展和患者结局有显著的关联.
*这些lncRNAs在质母细胞瘤细胞增殖中发挥了功能性作用,表明了治疗潜力.
*这些新型lncRNAs代表了有前途的生物标志物和扩散性质瘤的潜在治疗点.

更多相关视频

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...